CD28 and acute lymphoblastic leukemia: NK92 cells overexpressing a CD3-CAR containing the costimulatory domains of 4-1BB and CD28 had shown cytotoxic activity against peripheral T-cell lymphoma and T-ALL cells in vitro and reduction in tumor burden in a xenograft model [17].